跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,019 条关于
“Xuanzhu Biopharma”
全部
2,019
临床试验
17
药物
409
机构
205
资讯
1,388
去年
Akamis Bio Secures $60 Million for Cancer Gene Therapy Development and Partners with Xuanzhu Biopharma
5个月前
Xuanzhu Biopharma's DiLuoAke Demonstrates Superior Efficacy Over Crizotinib in Phase III ALK-Positive NSCLC Trial
5个月前
Boston Oncology Secures $100M+ Licensing Deal for Chinese Cancer Drugs in Middle East and North Africa
去年
China Approves Xuanyuening (Bireociclib): First Dual-Indication CDK Inhibitor for Advanced Breast Cancer
6个月前
Sihuan Pharmaceutical's Bireociclib Receives NMPA Approval for First-Line HR+/HER2- Advanced Breast Cancer Treatment
2年前
Bispecific Antibody-Drug Conjugates Show Promise in Solid Tumor Treatment
2年前
Immix Biopharma's NXC-201 Shows Promise as Outpatient CAR-T Therapy in Amyloidosis and Multiple Myeloma
3个月前
India Launches Biopharma SHAKTI Initiative, Targets 100 Biologics by 2047 to Become Global Biopharma Hub
去年
Harbour BioMed Appoints Yajie Li as Chief Medical Officer to Advance Antibody Therapeutics Pipeline
2年前
Kaida BioPharma Advances Novel Therapies for Gynecological Cancers, Launches Social Media Channels
第 1 页,共 139 页
上一页
下一页